Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. [electronic resource]
Producer: 20050628Description: 77-82 p. digitalISSN:- 0959-4973
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Carcinoma, Lobular -- drug therapy
- Disease Progression
- Docetaxel
- Drug Administration Schedule
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematologic Agents -- administration & dosage
- Humans
- Middle Aged
- Neoplasm Staging
- Neutropenia -- chemically induced
- Survival Analysis
- Taxoids -- administration & dosage
- Time Factors
- Treatment Failure
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.